Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Gastric Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• HER3-DXd

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced Solid Tumor, Melanoma | Phase 2 | Status: RECRUITING